MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Potential BlockBuster Technology and/or Business Model
Alveo Technologies
Organization & Developments: Alveo Technologies
Parents
Alveo Technologies
Children
*Alveo Technologies claims to be the first company to make molecular detection and diagnostics universally accessible – on the farm, in the field, in the clinic, or in the manufacturing plant – helping prevent or significantly limit the destructive impact of viruses, fungi, bacteria, and other pathogens by detecting earlier at the Point of Need™
*Developer of diagnostics technology using datasets to track global infectious disease outbreaks
*IntelliSense™ molecular detection technology
*Molecular detection using a handheld analyzer enables rapid, actionable pathogen detection in a growing number of fields precisely when — and where — it matters most.
*The Alveo platform brings molecular detection out of the lab and into the field
2024: Alveo Technologies Begins Shipping the First Point-of-Need™ Molecular Test for Avian Influenza in Poultry to the EU
2024: Alveo Technologies Enters Agreement with CDC to Develop a Point of Need Spatial Multiplexed Test for Avian Influenza A(H5) Virus in Humans
Jumps
Finance & Acquisition: Alveo Technologies
Key People: Alveo Technologies